Potential roles and molecular mechanisms of bioactive ingredients in Curcumae Rhizoma against breast cancer
- PMID: 37075623
- DOI: 10.1016/j.phymed.2023.154810
Potential roles and molecular mechanisms of bioactive ingredients in Curcumae Rhizoma against breast cancer
Abstract
Background: Breast cancer is the most prevalent cancer worldwide, with high morbidity and mortality. Despite great advances in the therapeutic strategies, the survival rate in the past decades of patients with breast cancer remains unsatisfactory. Growing evidence has demonstrated that Curcumae Rhizoma, called Ezhu in Chinese, showed various pharmacological properties, including anti-bacterial, anti-oxidant, anti-inflammatory and anti-tumor activities. It has been widely used in Chinese medicine to treat many types of human cancer.
Purpose: To comprehensively summarize and analyze the effects of active substances in Curcumae Rhizoma on breast cancer malignant phenotypes and the underlying mechanisms, as well as discuss its medicinal value and future perspectives.
Method: We used "Curcumae Rhizoma" or the name of crude extracts and bioactive components in Curcumae Rhizoma in combination with "breast cancer" as key words. Studies focusing on their anti-breast cancer activities and mechanisms of action were extracted from Pubmed, Web of Science and CNKI databases up to October 2022. The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) 2020 guideline was followed.
Results: Crude extracts and 7 main bioactive phytochemicals (curcumol, β-elemene, furanodiene, furanodienone, germacrone, curdione and curcumin) isolated from Curcumae Rhizoma have shown many anti-breast cancer pharmacological properties, including inhibiting cell proliferation, migration, invasion and stemness, reversing chemoresistance, and inducing cell apoptosis, cycle arrest and ferroptosis. The mechanisms of action were involved in regulating MAPK, PI3K/AKT and NF-κB signaling pathways. In vivo and clinical studies demonstrated that these compounds exhibited high anti-tumor efficacy and safety against breast cancer.
Conclusion: These findings provide strong evidence that Curcumae Rhizoma acts as a rich source of phytochemicals and has robust anti-breast cancer properties.
Keywords: Breast cancer; Chemoresistance; Curcumae Rhizoma; Curcumin; Metastasis.
Copyright © 2023 Elsevier GmbH. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest None.
Similar articles
-
Terpenoids from Curcumae Rhizoma: Their anticancer effects and clinical uses on combination and versus drug therapies.Biomed Pharmacother. 2021 Jun;138:111350. doi: 10.1016/j.biopha.2021.111350. Epub 2021 Mar 13. Biomed Pharmacother. 2021. PMID: 33721752 Review.
-
Curcumae Rhizoma: An anti-cancer traditional Chinese medicine.Chin Herb Med. 2025 Apr 24;17(3):428-447. doi: 10.1016/j.chmed.2025.04.006. eCollection 2025 Jul. Chin Herb Med. 2025. PMID: 40734908 Free PMC article. Review.
-
Anti-cancer properties of terpenoids isolated from Rhizoma Curcumae--a review.J Ethnopharmacol. 2012 Sep 28;143(2):406-11. doi: 10.1016/j.jep.2012.07.009. Epub 2012 Jul 20. J Ethnopharmacol. 2012. PMID: 22820242 Review.
-
Therapeutic Effects of Curcumol in Several Diseases; An Overview.Nutr Cancer. 2021;73(2):181-195. doi: 10.1080/01635581.2020.1749676. Epub 2020 Apr 14. Nutr Cancer. 2021. PMID: 32285707 Review.
-
The processing mechanism of vinegar-processed Curcumae Rhizome enhances anti hepatic fibrotic effects through regulation of PI3K/Akt/mTOR signaling pathway.Phytomedicine. 2024 Dec;135:156098. doi: 10.1016/j.phymed.2024.156098. Epub 2024 Sep 28. Phytomedicine. 2024. PMID: 39395324
Cited by
-
Eucommia ulmoides seed oil is a complementary food for suppressing digestive tumors.Front Pharmacol. 2025 Jun 18;16:1564999. doi: 10.3389/fphar.2025.1564999. eCollection 2025. Front Pharmacol. 2025. PMID: 40606608 Free PMC article.
-
Revealing the Mechanism of Esculin in Treating Renal Cell Carcinoma Based on Network Pharmacology and Experimental Validation.Biomolecules. 2024 Aug 22;14(8):1043. doi: 10.3390/biom14081043. Biomolecules. 2024. PMID: 39199428 Free PMC article.
-
Treatment strategies targeting the phosphoinositide 3-kinase/protein kinase B/mechanistic target of rapamycin pathway against triple-negative breast cancer.World J Clin Oncol. 2025 May 24;16(5):104623. doi: 10.5306/wjco.v16.i5.104623. World J Clin Oncol. 2025. PMID: 40503407 Free PMC article. Review.
-
Nanobiotechnology boosts ferroptosis: opportunities and challenges.J Nanobiotechnology. 2024 Oct 8;22(1):606. doi: 10.1186/s12951-024-02842-5. J Nanobiotechnology. 2024. PMID: 39379969 Free PMC article. Review.
-
Role of Curcuma longae Rhizoma in medical applications: research challenges and opportunities.Front Pharmacol. 2024 Aug 6;15:1430284. doi: 10.3389/fphar.2024.1430284. eCollection 2024. Front Pharmacol. 2024. PMID: 39170702 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous